Johannesen, K.* ; Mitter, D.* ; Janowski, R. ; Roth, C.* ; Toulouse, J.* ; Poulat, A.* ; Ville, D.M.* ; Chatron, N.* ; Brilstra, E.* ; Geleijns, K.* ; Born, A.P.* ; McLean, S.* ; Nugent, K.* ; Baynam, G.* ; Poulton, C.* ; Dreyer, L.* ; Gration, D.* ; Schulz, S.* ; Dieckmann, A.* ; Helbig, K.L.* ; Merkenschlager, A.* ; Jamra, R.* ; Finck, A.* ; Gardella, E.* ; Hjalgrim, H.* ; Mirzaa, G.* ; Brancati, F.* ; Bierhals, T.* ; Denecke, J.* ; Hempel, M.* ; Lemke, J.R.* ; Rubboli, G.* ; Muschke, P.* ; Guerrini, R.* ; Vetro, A.* ; Niessing, D. ; Lesca, G.* ; Moller, R.S.*
Defining and expanding the phenotype of QARS-associated developmental epileptic encephalopathy.
Neurol. Genet. 5:e373 (2019)
Objective The study is aimed at widening the clinical and genetic spectrum and at assessing genotype-phenotype associations in QARS encephalopathy. Methods Through diagnostic gene panel screening in an epilepsy cohort, and recruiting through GeneMatcher and our international network, we collected 10 patients with biallelic QARS variants. In addition, we collected data on 12 patients described in the literature to further delineate the associated phenotype in a total cohort of 22 patients. Computer modeling was used to assess changes on protein folding. Results Biallelic pathogenic variants in QARS cause a triad of progressive microcephaly, moderate to severe developmental delay, and early-onset epilepsy. Microcephaly was present at birth in 65%, and in all patients at follow-up. Moderate (14%) or severe (73%) developmental delay was characteristic, with no achievement of sitting (85%), walking (86%), or talking (90%). Additional features included irritability (91%), hypertonia/spasticity (75%), hypotonia (83%), stereotypic movements (75%), and short stature (56%). Seventy-nine percent had pharmacoresistant epilepsy with mainly neonatal onset. Characteristic cranial MRI findings include early-onset progressive atrophy of cerebral cortex (89%) and cerebellum (61%), enlargement of ventricles (95%), and age-dependent delayed myelination (88%). A small subset of patients displayed a less severe phenotype. Conclusions These data revealed first genotype-phenotype associations and may serve for improved interpretation of new QARS variants and well-founded genetic counseling.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Transfer-rna-synthetase; Ilae Commission; Position Paper; Mutations; Classification; Deficiency; Features
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
2376-7839
e-ISSN
2376-7839
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 5,
Heft: 6,
Seiten: ,
Artikelnummer: e373
Supplement: ,
Reihe
Verlag
American Academy of Neurology
Verlagsort
Minneapolis, Minn.
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503091-001
Förderungen
Copyright
Erfassungsdatum
2020-02-28